Search research articles
Contact Us
Filters
Showing results (291-300 of 311) with videos related to
Page
of 32
Sort By:
The Lancet. Oncology
|
April 1, 2024
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial
Jean-Pascal Machiels, Yungan Tao, Lisa Licitra, et al.
Oral Oncology
|
February 21, 2026
An observational retro-prospective study on patients with head and neck cancer who contracted COVID-19 (HERODOTUS: head and neck cancERs international cOviD-19 collabOraTion)
Panagiota Economopoulou, Abraham Pouliakis, Miltiades Kyprianou, et al.
Head & Neck
|
May 17, 2014
Measuring quality of life in patients with head and neck cancer: Update of the EORTC QLQ-H&N Module, Phase III
Susanne Singer, Cláudia Araújo, Juan Ignacio Arraras, et al.
The Lancet Regional Health. Europe
|
February 22, 2024
Management of patients with rare adult solid cancers: objectives and evaluation of European reference networks (ERN) EURACAN
Jean-Yves Blay, Paolo Casali, Isabelle Ray-Coquard, et al.
Head & Neck
|
October 27, 2020
Development of a multiomics database for personalized prognostic forecasting in head and neck cancer: The Big Data to Decide EU Project
Stefano Cavalieri, Loris De Cecco, Ruud H Brakenhoff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 29, 2025
INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab Plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Jérôme Fayette, Lisa Licitra, Kevin Harrington, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 15, 2024
The european organisation for research and treatment of cancer head and neck cancer module (EORTC QLQ-HN43): Estimates for minimal important difference and minimal important change
Susanne Singer, Eva Hammerlid, Iwona M Tomaszewska, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
July 17, 2021
Methodological approach for determining the Minimal Important Difference and Minimal Important Change scores for the European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module (EORTC QLQ-HN43) exemplified by the Swallowing scale
Susanne Singer, Eva Hammerlid, Iwona M Tomaszewska, et al.
Journal of the American Academy of Dermatology
|
October 15, 2023
Phase 2 open-label, multicenter, single-arm study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy: Extended follow-up
Alexander J Stratigos, Aleksandar Sekulic, Ketty Peris, et al.
Head & Neck
|
January 13, 2019
International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ-HN43: Phase IV
Susanne Singer, Cecilie Delphin Amdal, Eva Hammerlid, et al.
Page
of 32
Search research articles
Search
Showing results (291-300 of 311) with videos related to
Sort By:
Page
of 32
The Lancet. Oncology
|
April 1, 2024
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial
Jean-Pascal Machiels, Yungan Tao, Lisa Licitra, et al.
Oral Oncology
|
February 21, 2026
An observational retro-prospective study on patients with head and neck cancer who contracted COVID-19 (HERODOTUS: head and neck cancERs international cOviD-19 collabOraTion)
Panagiota Economopoulou, Abraham Pouliakis, Miltiades Kyprianou, et al.
Head & Neck
|
May 17, 2014
Measuring quality of life in patients with head and neck cancer: Update of the EORTC QLQ-H&N Module, Phase III
Susanne Singer, Cláudia Araújo, Juan Ignacio Arraras, et al.
The Lancet Regional Health. Europe
|
February 22, 2024
Management of patients with rare adult solid cancers: objectives and evaluation of European reference networks (ERN) EURACAN
Jean-Yves Blay, Paolo Casali, Isabelle Ray-Coquard, et al.
Head & Neck
|
October 27, 2020
Development of a multiomics database for personalized prognostic forecasting in head and neck cancer: The Big Data to Decide EU Project
Stefano Cavalieri, Loris De Cecco, Ruud H Brakenhoff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 29, 2025
INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab Plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Jérôme Fayette, Lisa Licitra, Kevin Harrington, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 15, 2024
The european organisation for research and treatment of cancer head and neck cancer module (EORTC QLQ-HN43): Estimates for minimal important difference and minimal important change
Susanne Singer, Eva Hammerlid, Iwona M Tomaszewska, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
July 17, 2021
Methodological approach for determining the Minimal Important Difference and Minimal Important Change scores for the European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module (EORTC QLQ-HN43) exemplified by the Swallowing scale
Susanne Singer, Eva Hammerlid, Iwona M Tomaszewska, et al.
Journal of the American Academy of Dermatology
|
October 15, 2023
Phase 2 open-label, multicenter, single-arm study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy: Extended follow-up
Alexander J Stratigos, Aleksandar Sekulic, Ketty Peris, et al.
Head & Neck
|
January 13, 2019
International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ-HN43: Phase IV
Susanne Singer, Cecilie Delphin Amdal, Eva Hammerlid, et al.
Page
of 32